Harris, Ross JRoss JHarrisSterne, Jonathan A CJonathan A CSterneAbgrall, SophieSophieAbgrallDabis, FrançoisFrançoisDabisReiss, PeterPeterReissSaag, MichaelMichaelSaagPhillips, Andrew NAndrew NPhillipsChêne, GenevièveGenevièveChêneGill, John MJohn MGillJustice, Amy CAmy CJusticeRockstroh, JürgenJürgenRockstrohSabin, Caroline ACaroline ASabinMocroft, AmandaAmandaMocroftBucher, Heiner CHeiner CBucherHogg, Robert SRobert SHoggMonforte, Antonella D'ArminioAntonella D'ArminioMonforteMay, MargaretMargaretMayEgger, MatthiasMatthiasEgger0000-0001-7462-51322024-10-132024-10-132008https://boris-portal.unibe.ch/handle/20.500.12422/101165BACKGROUND: In HIV type-1-infected patients starting highly active antiretroviral therapy (HAART), the prognostic value of haemoglobin when starting HAART, and of changes in haemoglobin levels, are not well defined. METHODS: We combined data from 10 prospective studies of 12,100 previously untreated individuals (25% women). A total of 4,222 patients (35%) were anaemic: 131 patients (1.1%) had severe (<8.0 g/dl), 1,120 (9%) had moderate (male 8.0-<11.0 g/dl and female 8.0- < 10.0 g/dl) and 2,971 (25%) had mild (male 11.0- < 13.0 g/ dl and female 10.0- < 12.0 g/dl) anaemia. We separately analysed progression to AIDS or death from baseline and from 6 months using Weibull models, adjusting for CD4+ T-cell count, age, sex and other variables. RESULTS: During 48,420 person-years of follow-up 1,448 patients developed at least one AIDS event and 857 patients died. Anaemia at baseline was independently associated with higher mortality: the adjusted hazard ratio (95% confidence interval) for mild anaemia was 1.42 (1.17-1.73), for moderate anaemia 2.56 (2.07-3.18) and for severe anaemia 5.26 (3.55-7.81). Corresponding figures for progression to AIDS were 1.60 (1.37-1.86), 2.00 (1.66-2.40) and 2.24 (1.46-3.42). At 6 months the prevalence of anaemia declined to 26%. Baseline anaemia continued to predict mortality (and to a lesser extent progression to AIDS) in patients with normal haemoglobin or mild anaemia at 6 months. CONCLUSIONS: Anaemia at the start of HAART is an important factor for short- and long-term prognosis, including in patients whose haemoglobin levels improved or normalized during the first 6 months of HAART.enarticle10.7892/boris.2776419195321000262341200001